Literature DB >> 2947262

Side branch occlusion complicating percutaneous transluminal coronary angioplasty.

L M Boxt, M F Meyerovitz, R H Taus, P Ganz, P L Friedman, D C Levin.   

Abstract

A frequent concern during angioplasty is the possibility of occluding important side branches that originate in arterial stenoses subjected to balloon dilatation. The effect of dilatation on 93 side branches (greater than or equal to 1 mm in diameter) was evaluated in 86 patients undergoing percutaneous transluminal coronary angioplasty (PTCA) in whom those branches arose directly in dilated segments of the left anterior descending, circumflex, or right coronary arteries. Seventy-six of the 93 side branches had minor (less than 50%) narrowing at their origin. Among these side branches, nine (12%) were compromised by PTCA. Seventeen of the 93 side branches had greater than 50% ostial stenosis. Significantly more of these side branches (seven of seventeen, or 41%) were compromised by PTCA (P less than .01). Even when compromise does occur, it usually takes the form of increased stenosis rather than total occlusion. The presence of side branches originating in stenotic lesions is not a contraindication to PTCA since serious compromise of such branches rarely results from this procedure.

Entities:  

Mesh:

Year:  1986        PMID: 2947262     DOI: 10.1148/radiology.161.3.2947262

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  2 in total

1.  Unusual transplant renal angioplasty complication: case report.

Authors:  I D Weisman; A L Ney; J H Andrisevic; W Stanchfield; M D Odland; R C Andersen
Journal:  Cardiovasc Intervent Radiol       Date:  1988-04       Impact factor: 2.740

2.  Clinical and angiographic predictors of major side branch occlusion after main vessel stenting in coronary bifurcation lesions.

Authors:  Dong Zhang; Bo Xu; Dong Yin; Yi-Ping Li; Yuan He; Shi-Jie You; Shu-Bin Qiao; Yong-Jian Wu; Hong-Bing Yan; Yue-Jin Yang; Run-Lin Gao; Ke-Fei Dou
Journal:  Chin Med J (Engl)       Date:  2015-06-05       Impact factor: 2.628

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.